ReviewCureus2024
Seroprevalence of Measles Antibodies Among Migrant Populations: A Systematic Review and Meta-Analysis.
Review in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Evaluation of vaccine immunity against tetanus, hepatitis B, measles, mumps, rubella and varicella, in migrant adolescents aged 13 to 18 years arriving in Geneva in 2023.European journal of pediatrics · 2026Observational
- History of the measles epidemics in Colombia: an incomplete countBiomedica : revista del Instituto Nacional de Salud · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Incomplete or interrupted vaccination schedules put migrant communities at higher risk for measles, which remains a serious public health concern. The objective of this systematic review was to evaluate the pooled seroprevalence of measles antibodies among migrant groups globally and offer data to guide public health initiatives. Our literature search included PubMed, Scopus, and Embase databases, covering publications from 1990 to 2023, and was systematically refined using specific inclusion and exclusion criteria. Only observational studies documenting measles antibody seroprevalence among defined migrant groups were included to ensure relevance and quality in addressing the study's objective. Meta-analytical techniques such as random-effects models were employed to assess pooled seroprevalence. The meta-analysis comprised 36 studies with 42,972 participants in total. Among migrant communities, the overall pooled seroprevalence of measles antibodies was 83% (95%CI: 80%-87%). Studies showed significant heterogeneity (I
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.